| Literature DB >> 35278750 |
Muhammad Chutiyami1, Umar Muhammad Bello2, Dauda Salihu3, Dorothy Ndwiga4, Mustapha Adam Kolo5, Reshin Maharaj4, Kogi Naidoo6, Liza Devar4, Pratitha Pratitha4, Priya Kannan7.
Abstract
BACKGROUND: The COVID-19 pandemic has continued to cause unprecedented concern across the globe since the beginning of the outbreak. Healthcare workers, particularly those working on the front line, remain one of the most affected groups. Various studies have investigated different aspects of the physical health of healthcare workers; however, limited evidence on the overall physical health of healthcare workers has been collectively examined. AIM: To examine the various aspects of physical health and well-being of healthcare workers during the COVID-19 pandemic.Entities:
Keywords: COVID-19; Healthcare workers; Mortality; Review of review; Well-being
Mesh:
Year: 2022 PMID: 35278750 PMCID: PMC8855608 DOI: 10.1016/j.ijnurstu.2022.104211
Source DB: PubMed Journal: Int J Nurs Stud ISSN: 0020-7489 Impact factor: 6.612
Fig. 1PRISMA flow chart indicating the study selection process.
Characteristics of Included studies and participants.
| No | Author | Year | Gender/age (years) | Search strategy | Studies included/and participants | Outcomes/validated tool | Risk of bias/Instrument used | Country of studies | Comorbidities |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Al Maqbali et al. | 2021 | Age: NR | Databases used: PubMed, CINAHL, Medline, Embase, PsycINFO, MedRxiv and Google Scholar. | Number of studies included: 93 | Depression, stress, anxiety, and sleep disturbances/validated tool (DASS-21, SCL-90, IES-R, GAD-7, PHQ-4, 9; PSS-4, ISI, SRQ-20, SAS, SDS, PCL-5, HADS, PSQI, PTSD, SOS, ASDI, BDI, HAM-A, STAI, SRSS, WSP, PDSS, BAI, CAS, AIS, and NSS). | Low-medium quality studies/NOS checklist | Austria, Bahrain, Bolivia, China, Croatia, Ecuador, Egypt, Ethiopia, France, Germany | None |
| 2 | Bandyopadhyay et al. | Age: 18–84 years | Databases used: Medline and Embase | Number of studies included: 594 | Number of healthcare workers infected/died with COVID-19 | Good/AACODS checklist or NIH study quality | Afghanistan, Algeria, Argentina, Armenia, Australia, Austria, Bahamas, Bangladesh, Belgium, Bosnia-Herzegovina Brazil, Bulgaria, Cameroon, Canada, Chile, China, Colombia, Crotia, Cuba, Cyprus, Czechia, Denmark, Dominican-Republic, Ecuador, Egypt, Estonia, Finland, Germany, Ghana, France, Greece, Guyana, Hungary, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Kazakhstan, KSA, Kuwait, Kyrgyzstan, Lithuania, Malaysia, Maldova, Mexico, Netherlands, New Zealand, Niger, Nigeria, Pakistan, Panama, Peru | None | |
| 3 | de Pablo et al., | 2021 | Age: Mean age was 36.1 ± 7.1 years; ranges from 23 to 69.4years. | Databases used: The Russian Science Citation Index, the BIOSIS Citation Index, Web of Science Core Collection, the KCI-Korean Journal Database, MEDLINE, and the SciELO Citation Index, | Number of studies included: 115 | Psychological distress, anxiety, depressive symptoms, PTSD, burnout, fear, stigmatization feelings, general health concerns, Insomnia, and somatisation/ Self-administered questionnaires, interviews/evaluations, or surveys. | Quality ranged from 1 to 5 (MMAT score) | Canada | None |
| 4 | Gómez-Ochoa et al. | Age: Mean age 40 | Databases used: the World Health Organization COVID-19 database, Caribbean Health Sciences Literature (LILACS), Embase, Medline, Web of Science, Google Scholar, Cochrane, and the University of Bern Institute of Social and Preventive Medicine database. | Number of studies included: 97 | Prevalence, and associated factors of SARS-CoV-2 infection in healthcare professionals/NR | Moderate quality ( | Belgium, China, France, France, Germany, India | Hypertension, cardiovascular | |
| 5 | Gross et al. | Age: NR | Databases used: PubMed, Web of Science and PsycINFO | Number of studies included: 27. | Prevalence and severity of infections, risk factors, mortality rates, physical and psychological burden, depression, anxiety, distress, PTSD, somatisation, obsessive-compulsive disorder, Self-efficacy, Stress, anxiety dreams, sleep quality or insomnia/SDS, SAS, DASS-21, IES-R, CES-D, PSQI, PHQ-9, GAD-7, ISI, NRS, HAMA, HAMD, SOS, DASS-21, GSES, SASR, SF-36, SCL-90R, PHQ-4. | Low to moderate quality/AXIS tool, CASP checklist, JBI Critical Appraisal Checklist and GRADE | China | None | |
| 6 | Krishnamoorthy et al. | Age: mean age 30.6 to 49.9 years | Databases used: Chinese, Google Scholar, Medline, national knowledge | Number of studies included: 50 | sleep quality, stress, psychological distress, insomnia, post-traumatic stress symptoms, anxiety, depression/ validated tool (PCL-C, GAD, PHQ, SDS | High risks of bias/NOS | China | None | |
| 7 | Kunz et al. | Age: NR | Databases used: NR | Number of studies included: 27 | Depression, anxiety, stress, sleep, post-traumatic stress, burnout, substance use disorder, and somatization/validated tools (HADS, PHQ-9, PHQ-8, DASS-21, BDI, PHQ-2, GAD-7, GAD-2, SAS, HARS, ISI, IES-R, PSS-14, STAI-Y, EASE, GPS, PCL-5, PDEG, ProQOL-5, MBI, PFI, CAGE-AID). | NR/JBI-checklist | Australia | None | |
| 8 | Lee et al. | 2020 | Age: median age 62.0years | Databases used: EMBASE, Medline, PubMed, and Cochrane Central Register of Controlled Trials (CENTRAL). | Number of studies included: 61 | Types of surgical procedures performed (elective, urgent, or oncologic), the incidence of infected patients (confirmed or presumed) for COVID-19, SARS, MERS, and Ebola, number of negative infections, types of personal protective effective equipment used/NR | Fair quality/MINORS | Canada, China, France | None |
| 9 | Mahmud et al. | Age: 15–28years | Databases used: MEDLINE, PubMed, Web of Science, and Google Scholar databases. | Number of studies included: 69 | Depression, anxiety, insomnia/ validated tools (CES-D, DASS-21, HADS, PHQ, and SDS, ISR, HAMD, FCV-19S, PDI, PHQ-4, PSSQ EASE, PHQ-15, SAVE-9, BAI, ISI, PSQI, GAD, HAM-A, IES, PSS, PTSD-8, and AIS. | Average STROBE score 21.54/STROBE checklist | Australia, Bangladesh, Canada, China, Croatia, Egypt, Finland, Germany, Ghana, Greek, India, Iran, Italy, Jordan, Korea, KSA, | None | |
| 10 | Moitra et al. | Age: NR | Databases used: PubMed and Embase. | Number of studies included: 51 | Anxiety symptoms, depressive symptoms, sleep quality, psychological trauma, insomnia, workplace burnout, fatigue, and distress/validated tools (PHQ, and GAD were the most commonly used measures; others were the PSQI). | NR | Brazil, Canada, China, India, Iran, Italy, KSA, Kuwait, Lebanon, Pakistan, Romania, Serbia, South Korea, Spain, Sweden, Taiwan, UK, USA | None | |
| 11 | Sahu et al. | Age: NR | Databases used: Web of Science, PubMed, and EMBASE | Number of studies included: 11 | Number of healthcare workers infected with COVID −19, critically and severely ill and healthcare workers/NR | Good quality/AXIS tool | China | None | |
| 12 | Shaukat et al. | Age: NR | Databases used: PubMed and Google Scholar | Number of studies included: 10 | Depression, anxiety, insomnia, and distress/validated tools (IES-R, PTSD-rating scale, ISI, GAD-7, SASR, Self-rating scale, GSES, and social support rating scale. | NR | China | None | |
| 13 | Varghese et al. | Age: 21–45 years | Databases used: PUBMED, MEDLINE, Psych Info, Google Scholar, Nursing and Allied Health Database, Science Direct, Corona Virus Research Database and Web of Science Core Collection. | Number of studies included: 25 | Depression, anxiety, stress, PTSD, and insomnia/validated tools (GAD, SAS, CAS, GSI, STAI, HADS, SASRQ, GSI, PHQ-9, DASS-21, IES, PCL-C, PSS, HAMD and Self-reported Stressor and Incidence Questionnaire). | Moderate to high quality/Loney criteria | Brazil | None |
NOS=Newcastle-Ottawa Scale; PTSD=Post-traumatic stress disorder; PSS=Perceived Stress Scale; IES=Impact of Event Scale; DASS-21=Depression Anxiety Stress Scale; GHQ-28=28-item General Health Questionnaire; BDI=Beck Depression Inventory; GSES=General Self-Efficacy Scale; SASRQ=Stanford Acute StressReaction Questionnaire; PSQI=Pittsburgh Sleep Quality Index; ISI=Insomnia Severity Index; NR=Not Reported; BAI=Beck's Anxiety Inventory; GAD-7=General Anxiety Disorder 7-items; WHO-5=WHO-Five Well- Being Index; SDS=Self-Rating Depression Scale; HADS=Hospital Anxiety and Depression Scale; IES-=Impact ofEvent Scale-Revised; GPS-PTSS=Global Psychotrauma Screen, SCL-90=Symptom Check-List 90; SCL-90-R=Symptom Check List-90-revised;; HAM-=Hamilton Anxiety Scale; HAMD=Hamilton Depression Scale; PHQ=Patient Health Questionnaire; SAS=Zung's self-rating anxiety scale; AIS=Athen's Insomnia Scale; SOS=StressOverload Scale; STAI=State-Trait AnxietyInventory; MBI=Maslach Burnout Inventory; CES-=centre for Epidemiologic Studies Depression Scale; SRQ=Stress Reaction Questionnaire; PTSD-SS=post-traumatic stress disorder self-rating scale; CASP=Critical Appraisal Skills Programme appraisal tool; JBI-checklist=Joanna BriggsInstitute checklist; PSS-10=Perceived Stress Scale; PSS-14=Perceived Stress Scale; GSI=Global Severity Index; HARS=Hamilton Anxiety Rating Scale; STAI-=State Anxiety Inventory-trait form; EASE=Acute Stress of Health Professionals Caring COVID-19 scale; PCL-5=Post-traumatic Checklist-5; PDEG=Peritraumatic Disso-ciation Questionnaire; ProQOL-5=Professional Quality of Life Scale; PFI=Stanford Professional fulfilment Index; CAGE-AID=Substance Abuse screening tool; CPDI CoViD-19=Peritraumatic Distress Index; GPS-PTSD=Global Psychotrauma Scale-posttraumatic stress disorder subscale; SASR=Stanford Acute Stress Reaction;STROBE checklist=Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statements; ASDI=Acute Stress Disorder Inventory; SRSS=Sleep Self-Assessment Scale; WSP=Work Stress Profile; PDSS=Panic Disorder Severity Scale; CAS=Coronavirus Anxiety Scale; MMAT=Mixed Method Appraisal Tool;ISR= ICD-10-Symptom-Rating; PSSQ=Postpartum Social Support Questionnaire; PDI= Pain Disability Index; SAVE-9=Stress and Anxiety to Viral Epidemics – 9; PTSD-8=Short PTSD Inventory; NSS= Nursing Stress Scale; AXIS=Appraisal tool for Cross-Sectional Studies; USA=United States of America; UK=United Kingdom;KSA=Kingdom of Saudi Arabia.
Outcome of the critical appraisal of the included studies.
| S/ no | Study refs. | Criteria assessed based on JBI checklist | Total criteria met | Quality ranking | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||||
| 1 | Al Maqbali et al. (2021) | Y | Y | Y | Y | Y | U | U | Y | Y | Y | Y | 9 | High |
| 2 | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | Y | 10 | High | |
| 3 | Y | Y | Y | Y | Y | U | Y | Y | N | Y | N | 8 | High | |
| 4 | Y | Y | Y | Y | Y | Y | Y | Y | N | Y | U | 9 | High | |
| 5 | Y | Y | Y | Y | Y | U | U | Y | N | Y | Y | 8 | High | |
| 6 | Y | Y | Y | Y | Y | Y | U | Y | Y | Y | N | 9 | High | |
| 7 | Y | Y | U | N | Y | Y | N | Y | N | Y | N | 6 | Medium | |
| 8 | Y | Y | Y | Y | Y | U | Y | Y | N | Y | Y | 9 | High | |
| 9 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 11 | High | |
| 10 | Y | Y | Y | Y | U | U | Y | Y | N | Y | U | 8 | High | |
| 11 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | U | 10 | High | |
| 12 | Y | Y | Y | N | U | U | U | Y | N | Y | N | 5 | Medium | |
| 13 | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | 11 | High | |
Criteria 1 to 11- 1: clarity of review question; 2: appropriateness of inclusion criteria; 3: appropriateness of search strategy; 4: adequacy of search sources; 5: appropriateness for criteria in appraising included studies; 6: appraisal conducted by 2 or more reviewers independently; 7: methods to minimize errors in data extraction; 8: appropriate methods to combine studies; 9: assessment of publication bias; 10: recommendation for policy/practice based on reported data.
COVID-19 mortalities, infection, symptoms, complications, skin injuries, poor sleep quality and work-related stress among healthcare workers.
| Outcome | Measure | Reference | Effect of COVID-19 on outcome | Effect size/comment | ||
|---|---|---|---|---|---|---|
| Compared | Overall/no comparison | |||||
| Significant | Not significant | |||||
| COVID-19 mortalities/ death rate | Estimate | ✓ | ||||
| Estimate | ✓ | |||||
| Estimate | ✓ | Ranged from 0.7% ( | ||||
| Estimate | ✓ | 0.3% (95%CI:0.2–0.4) | ||||
| COVID-19 infection prevalence /infection rate | Estimate | ✓ | ||||
| Estimate | ✓ | 31,866 infection, | ||||
| Estimate | ✓ | Ranged from 4.4% ( | ||||
| Estimate | ✓ | 8.6% ( | ||||
| Estimate | ✓ | 13,199 | ||||
| Estimate | ✓ | 33.7% ( | ||||
| Complications/ critical conditions | Estimate | ✓ | 5% (95%CI: 3–8), | |||
| Estimate | ✓ | 6%, | ||||
| Estimate | ✓ | 9.9%, (95%CI:0.8–18.9) | ||||
| Estimate | ✓ | |||||
| Comorbidities | Estimate | ✓ | 7% (95% CI: 4, 10) prevalence of hypertension; 3% (95% CI: 1, 8) cardiovascular disease; 4% (95% CI: 2, 7) type 2 diabetes; 3% (95% CI: 1, 6) chronic obstructive pulmonary disease. | |||
| Anosmia | Estimate | ✓ | OR = 28.37 (9.45–85.16) | |||
| Chills | Estimate | ✓ | 4.5% (95%CI:2–10) | |||
| Chest pain | Estimate | ✓ | 8% (95%CI: 1–18) N = 6 | |||
| Estimate | ✓ | |||||
| Cough | Estimate | ✓ | 56% (95%:40- 72) | |||
| Estimate | ✓ | 57% (95% CI: 50–65), | ||||
| estimate | ✓ | |||||
| diarrhea | estimate | ✓ | 12% (95%ci: 5–25) | |||
| Estimate | ✓ | 18% (95%CI: 14–22) | ||||
| estimate | ✓ | |||||
| dyspnea | estimate | ✓ | 20% (95%ci: 11–33) | |||
| Fatigue | Estimate | ✓ | 38% (95%CI: 15–67) | |||
| Estimate | ✓ | OR = 2.41 (95%CI: 0.92 – 6.27) N = 5 | ||||
| Fever | Estimate | ✓ | 71% (95%CI: 58–82) | |||
| Estimate | ✓ | 57% (95% CI: 50, 64) | ||||
| Estimate | ✓ | |||||
| Headache | Estimate | ✓ | 23% (95%CI: 7–55) | |||
| Estimate | ✓ | |||||
| Estimate | ✓ | |||||
| Haemoptysis | Estimate | ✓ | ||||
| Malaise | Estimate | ✓ | 43% (95% CI: 26–61) N = 1 | |||
| Estimate | ✓ | |||||
| Myalgias | Estimate | ✓ | 17.8% (95%CI: 4–51) | |||
| Estimate | ✓ | 48% (95% CI: 35–62) | ||||
| Nausea and vomiting | Estimate | ✓ | 7% (95%CI: 0.8–43) | |||
| Estimate | ✓ | 9% (95%CI: 6–14) N = 7 | ||||
| Shortness of breath | Estimate | ✓ | 22% (95%CI: 17–28) | |||
| Sore throat | Estimate | ✓ | 20.7% (95%CI: 8–44) | |||
| Estimate | ✓ | OR = 0.55 (95%CI: 0.30 – 1.01). N = 3 | ||||
| Skin injuries due to PPE use | Estimate | ✓ | ||||
| Estimate | ✓ | |||||
| Poor sleep quality | PSQI | ✓ | 41% (95% CI 22–64), | |||
| PSQI | ✓ | 43% (28%−59%) | ||||
| Work-related stress | ASDI, SCL-90, IES-R; PSS, SOS, SRQ | ✓ | 43% (95% CI: 37–49), | |||
| NA | ✓ | 33% (19%−50%) | ||||
| NA | ✓ | 40% | ||||
| IES-R, DASS-21, PSS | ✓ | 44.86% (95% CI: 36.98–52.74) | ||||
| NA | ✓ | |||||
| NA | ✓ | 40.6% (95% CI = 25.4%−56.8%,) | ||||
Value was estimated from both research and report sources with unclear N;
total number of participants is unclear;
combined physical and mental stress; ASDI: Acute Stress Disorder Inventory; CFR: Case Fatality Rate; DASS-21: Depression, Anxiety Stress Scale; DFE: Doctors Fears and Expectations; IES-R Impact of Event Scale-Revised; NA: Not Available; OR: Odds Ratio; PPE: Personal Protective Equipment; PSQI Pittsburgh Sleep Quality Index; PSS Perceived Stress Scale; SOS: Stress Overload Scale; SRQ: Self Reporting Questionnaire.